EverSource Wealth Advisors, LLC

Position in PAHC — Phibro Animal Health Corp

CIK 1710537 BIRMINGHAM, AL

Back to PAHC Full portfolio

Position in PAHC

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$326,712

+$141,259 QoQ

Shares Held

5,907

+19.0% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PAHC Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

EverSource Wealth Advisors, LLC holds $3,753,691 across 50 Drug Manufacturers - Specialty & Generic names. PAHC ranks #4 (8.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	4,557	$600,332
2	HLN	Haleon plc	57,526	$575,830
3	TAK	Takeda Pharmaceutical Co Ltd	25,896	$479,586
4	PAHC	Phibro Animal Health Corp This page	5,907	$326,712
5	ZTS	Zoetis Inc.	2,285	$270,103
6	SUPN	Supernus Pharmaceuticals, Inc.	4,859	$251,159
7	ELAN	Elanco Animal Health Inc	9,415	$225,295
8	COLL	Collegium Pharmaceutical, Inc	5,035	$166,503

All Filings in PAHC

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$326,712	5,907	+19.0%	Shares	Sole	2026-05-18
2025-12-31	$185,453	4,964	+17.3%	Shares	Sole	2026-02-06
2025-09-30	$171,266	4,233	+55.6%	Shares	Sole	2025-11-10
2025-06-30	$69,467	2,720	+7671.4%	Shares	Sole	2025-08-13
2025-03-31	$747	35	-57.3%	Shares	Sole	2025-05-13
2024-12-31	$1,722	82	+24.2%	Shares	Sole	2025-02-10
2023-09-30	$842	66	-45.9%	Shares	Sole	2023-11-03
2023-06-30	$1,671	122	-52.7%	Shares	Sole	2023-08-04
2022-06-30	$4,935	258	0.0%	Shares	Sole	2022-08-01
2022-03-31	$5,147	258	—	Shares	Sole	2022-05-25
No filing history on record for this holder in this stock.